RVMD

merck-in-talks-to-acquire-revolution-medicines-for-about-$30b-–-wsj

ABBV Biotechnology MRK RVMD Uncategorized

Merck in talks to acquire Revolution Medicines for about $30B – WSJ

Jan 9, 2026

On the Move M&A Comments (18) Marko Georgiev/Getty Images News Merck (MRK) is in talks...

ABBV Biotechnology MRK RVMD Uncategorized

Revolution Medicines soars on report Merck in talks to buy (update)

Jan 8, 2026

Biotechnology RVMD Uncategorized

Revolution Medicines gains Breakthrough Therapy status for zoldonrasib

Jan 8, 2026

Biotechnology IMRX RVMD Uncategorized VSTM

Immuneering plummets following phase 2 data of atebimetinib for pancreatic cancer

Jan 7, 2026

ABBV Biotechnology RVMD Uncategorized

AbbVie says not in talks to buy Revolution Medicines

Jan 7, 2026

ABBV Biotechnology ERAS RVMD Uncategorized

Revolution Medicines jumps on report AbbVie nears takeover

Jan 7, 2026

ABVX Biotechnology CGON CNTA JANX LLY MDGL RCUS RVMD SLDB Uncategorized

Here are the most and least likely M&A targets in biotech, according to Truist

Dec 23, 2025